The Host Julie Rovner KFF Health News @jrovner Read Julie’s stories. Julie Rovner is chief Washington correspondent and host of KFF Health News’ weekly health policy news podcast, “What the Health?” A noted expert on health policy issues, Julie is the author of the critically praised reference book “Health Care Politics and Policy A to…
KFF Health News chief Washington correspondent Julie Rovner discussed Affordable Care Act subsidies on Crooked Media’s What a Day on Dec. 10 and on Slate’s What Next on Dec. 9. Click here to hear Rovner on What a Day. Click here to hear Rovner on What Next. KFF Health News Washington health policy reporter Amanda…
This KFF tracker provides up to date information on U.S. pledges thus far to four multilateral health replenishments (the Pandemic Fund, WHO, Gavi, and the Global Fund) and U.S. government support to date.
Lining the shelves of American supermarkets are food products with chemicals linked to health concerns. To a great extent, the FDA allows food companies to determine for themselves whether their ingredients and additives are safe. Companies don’t have to tell the FDA about those decisions, and they don’t have to list all ingredients on their…
KFF Health News senior correspondent Aneri Pattani discussed how states are using opioid settlement money on CBS News 24/7’s “The Daily Report” on Nov. 3. Click here to watch Pattani on “The Daily Report.” Read Pattani’s “From Narcan to Gun Silencers, Opioid Settlement Cash Pays Law Enforcement Tabs” and “Sock Hops and Concerts: How Some…
Dr. Bhattacharya, a US COVID policy critic, has been nominated by Trump to lead the country’s top public funder of medical research
It comes down to two simple questions that every health plan should consider: “Are we a company that pays for services and manages risks? Or are we a company that delivers better health for our members?” The post Healthcare’s Next Frontier: Building a Fully Connected Experience appeared first on MedCity News.
MedCity News Editor in Chief Arundhati Parmar and Samir Batra, managing partner of Health Innovation Pitch, also discussed whether bitcoin would play a greater role in healthcare deals and the Trump administration’s mixed messages on autism and Tylenol. The post Debunked Episode 20: A Look at H-1B Visas in Healthcare, M&A Deals for Bitcoin and…
That is the topic of a JMCP Viewpoint by Sean Sullivan, Jens Grueger, Aidan Sullivan, and Scott Ramsey. Some excerpts: The Budget Lab at Yale University projected that a 25% ad valorem tariff would increase medication costs by an “average of around $600 per year per household in the United States.”3 Tariffs can also create supply…
In this JAMA Health Forum column, Larry Levitt highlights how the Make America Healthy Again agenda aimed at chronic disease does little to address the affordability of health care and that efforts to lower federal spending on health care may worsen the problem, raising out-of-pocket costs for many people with Medicaid and Affordable Care Act…More